['diabetes, hyperlipidemia, mixed dyslipidemia']
['atorvastatin']

        Inclusion Criteria:

          -  Males and females with type 2 diabetes (receiving pharmacologic treatment for at least
             6 months or longer) with stable diabetes therapy

          -  Lipid-lowering therapy must be unchanged for at least 4 weeks or more

          -  Subjects receiving statin therapy at screening must have a fasting LDL-C of greater
             than or equal to 100 mg/dL

          -  Subjects not receiving statin therapy at screening must have a fasting LDL-C of
             greater than or equal to 130 mg/dL

        Exclusion criteria:

          -  New York Heart Association (NYHA) class III or IV heart failure

          -  Uncontrolled cardiac arrhythmia

          -  Uncontrolled hypertension

          -  Type 1 diabetes or poorly controlled type 2 diabetes

          -  Uncontrolled hypothyroidism or hyperthyroidism.
      